More on ORGO

- Summary
- Chart
- Profile
- Historical

Data

- Earnings (-250.0% Growth)
- Ratings (6.3 Score)

Upcoming Events

- Earnings (8/6/26)

News

- Analyst Ratings
- Earnings Related
- Guidance
- Insider Trades
- Mgmt Changes
- M & A
- Retail Sales
- Rumors
- Stock Buybacks
More...

Organogenesis Holding (NQ:ORGO)
Delayed: 2.52 -0.01 (0.4%)
Prev. Close $2.53  
Open$2.54 
52 Wk High$ 
52 Wk Low$ 
Day High$2.58 
Day Low$2.47 
P/E N/A  
EPS$ 
Volume419,838 

Friends, Peers and Foes (?): MDXG, AVR, AXGN, CERS, CVRX (more...)

Jul 27, 2026 04:05 PM Organogenesis publishes Affinity trial results for venous leg ulcers
Jul 27, 2026 04:05 PM Organogenesis Announces Publication of Peer-Reviewed Clinical Trial Results Demonstrating Clinical Benefit of Affinity™ in the Most Challenging and Complex Venous Leg Ulcers
Jul 9, 2026 07:30 AM Organogenesis Holdings Inc. to Report Second Quarter of Fiscal Year 2026 Financial Results on August 6, 2026
Jul 6, 2026 04:05 PM FDA accepts Organogenesis BLA for knee osteoarthritis treatment ReNu
Jul 6, 2026 04:05 PM Organogenesis Announces FDA Acceptance of Biologics License Application for ReNu® for the Management of Symptomatic Knee Osteoarthritis
Jun 18, 2026 12:43 PM Regenerative Medicine’s Next Chapter: Inside the Race to Make the Body Rebuild Itself
Jun 16, 2026 04:33 PM Form 8-K Organogenesis Holdings For: Jun 15
Jun 16, 2026 10:30 AM The Quiet Revolution in Regenerative Medicine: From Replacing Tissue to Rebuilding It
May 28, 2026 06:06 AM Truist Securities Starts Oranogenesis Holdings (ORGO) at Hold
May 8, 2026 05:33 AM BTIG Downgrades Oranogenesis Holdings (ORGO) to Neutral
View All Articles

Entities mentioned with ORGO

View All Entities